纳斯达克生物科技指数收涨1.56%。成分股Sutro Biopharma收涨20.04%，Mersana Therapeutics涨17.19%，Neurogene涨15.12%。Tempus AI收跌4.83%表现倒数第四，Prothena Plc.跌5.06%，Grail跌6.28%，OmniAb跌8.11%。

Group 1 - The NASDAQ Biotechnology Index increased by 1.56%, closing at 4,260.4, with a gain of 65.2 points [1][3] - Sutro Biopharma saw a significant rise of 20.04%, while Mersana Therapeutics and Neurogene also experienced notable increases of 17.19% and 15.12% respectively [1][3] - Other companies that performed well include Kyverna Therapeutics (+13.24%), Sana Biotechnology (+11.11%), and Larimar Therapeutics (+10.88%) [3] Group 2 - Tempus AI had a decline of 4.83%, ranking fourth from the bottom, followed by Prothena Plc. (-5.06%), Grail (-6.28%), and OmniAb (-8.11%) [2][4] - The overall performance of the biotechnology sector showed mixed results, with several companies experiencing significant losses alongside those that gained [2][4]